Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells

Summaryp16INK4A (p16) tumour suppressor induces growth arrest by inhibiting function of cyclin-dependent kinase (CDK)4 and CDK6. Homozygous p16 gene deletion is frequent in primary rhabdomyosarcoma (RMS) cells as well as derived cell lines. To confirm the significance of p16 gene deletion in tumour biology of RMS, a temperature-sensitive p16 mutant (E119G) gene was retrovirally transfected into the human RMS cell line RD, which has homozygous gene deletion of p16 gene. Decrease from 40°C (restrictive) to 34°C (permissive) culture temperature reduced CDK6-associated kinase activity and induced G1 growth arrest. Moreover, RD-p16 cells cultured under permissive condition demonstrated differentiated morphology coupled with expressions of myogenin and myosin light chain. These suggest that deletion of p16 gene may not only facilitate growth but also inhibit the myogenic differentiation of RD RMS cells.

[1]  C. Turc‐Carel,et al.  Consistent chromosomal translocation in alveolar rhabdomyosarcoma. , 1986, Cancer genetics and cytogenetics.

[2]  W. Cavenee,et al.  Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping , 1987, Nature.

[3]  P. Lollini,et al.  Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA). , 1989, Anticancer research.

[4]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[5]  E. Kohn,et al.  Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  J. Downing,et al.  Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. , 1993, Cancer research.

[7]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[8]  Jay W. Schneider,et al.  Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation , 1993, Cell.

[9]  K. Tanaka,et al.  Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. , 1994, Blood.

[10]  W. Gu,et al.  Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. , 1994, Science.

[11]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[12]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[13]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[14]  S. Tavtigian,et al.  Complex structure and regulation of the P16 (MTS1) locus. , 1995, Cancer research.

[15]  M. Tomonaga,et al.  Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. , 1995, Blood.

[16]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[17]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[18]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[19]  H. Varmus,et al.  Mutations associated with familial melanoma impair p16INK4 function , 1995, Nature Genetics.

[20]  G. Basso,et al.  Analysis of cyclin‐dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma , 1996, Genes, chromosomes & cancer.

[21]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[22]  K. Anderson,et al.  A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism. , 1996, Leukemia.

[23]  K. Anderson,et al.  Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. , 1996, Blood.

[24]  T. Jacks,et al.  Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle , 1996, The Journal of cell biology.

[25]  K. Walsh,et al.  Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis , 1996, The Journal of cell biology.

[26]  K. Anderson,et al.  Interleukin-6 Overcomes p21WAF1 Upregulation and G1 Growth Arrest Induced by Dexamethasone and Interferon-γ in Multiple Myeloma Cells , 1997 .

[27]  J. Decaprio,et al.  p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. , 1997, Blood.

[28]  J. Decaprio,et al.  Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.